Population Covered By The Guidance
This pathway provides guidance on the imaging investigation of an adult patient with a salivary gland swelling
Lead Researcher: Dr Ben Milne
Experts & Contributors: Dr Daren Gibson, Prof Peter Friedland, Dr Mark Fiorentino
Date reviewed: August 2025, Minor revision August 2026, Clin Prof Richard Mendelson
Date Published: December 2025
- There are many causes of salivary gland swelling, including:
- Neoplasms (benign or malignant)
- Sialolithiasis or ductal stenosis
- Infection (e.g. mumps, bacterial)
- Autoimmune diseases (e.g. Sjögren’s syndrome, IgG4-related dacroadenitis and sialadenitis)
- Sialadenosis from systemic diseases (e.g. diabetes mellitus, Cushing’s syndrome, metabolic disturbances)
- Lymphadenopathy or apparent swelling due to enlargement of adjacent structures
- Clinical history and examination are important to guide choice of imaging and for diagnosis, especially considerations of acuity of presentation, and presence of systemic features.
- Ultrasound is usually the first line imaging modality in undifferentiated salivary gland swelling and is recommended after 3 weeks of persistent salivary gland swelling.
- Certain “red flag” features include facial nerve palsy, suspected involvement of the deep lobe of the parotid, minor salivary gland, or a past medical history of scalp or facial skin cancers, should warrant urgent specialist referral and MRI for further investigation.
- Of all salivary gland tumours, 70% arise from the parotid gland. Of all parotid gland tumours, 75% of these are benign.
- When neoplasia is suspected, after ultrasound, MRI is the recommended complementary imaging modality.
- Imaging guided fine needle aspiration cytology of mass lesions is generally undertaken to guide further management, however may impair exact characterisation via MRI if performed in the previous 3 weeks.
- Surgery is the recommended treatment for the majority of both benign and malignant salivary gland neoplasms. Differentiating between benign and malignant neoplasms is important for surgical planning.
- Conventional or MR sialography can be used to identify or further characterise sialolithiasis or duct stricture, with conventional sialography being a potentially diagnostic and therapeutic procedure.
- CT investigation for salivary gland swelling is now considered a poor choice and can be falsely reassuring.
- There is evolving literature surrounding the exploration of utilising positron emission technology (PET) for both diagnostic and therapeutic options in salivary gland tumours, however this is not currently recommended in routine clinical practice and data are sparse.
- The need for staging CT chest or PET-CT should be guided by grade of tumour and risk of locoregional/distant disease, which will be dictated under specialist guidance.
- Alvi S, Chudek D, Limaiem F. Parotid Cancer. Statpearls. 2023 (Review Article). https://www.ncbi.nlm.nih.gov/books/NBK538340/#article-26690.s7
- Afzelius P, Nielsen MY, Ewertsen C, Bloch KP. Imaging of the major salivary glands. Clin Physiol Funct Imaging. 2016;36(1):1-10 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/25319072
- Mehanna H, McQueen A, Robinson M, Paleri V. Salivary gland swellings. BMJ. 2012;345(oct23 1):e6794-e (Review article). https://www.ncbi.nlm.nih.gov/pubmed/23418969
- Sobrino-Guijarro B, Cascarini L, Lingam RK. Advances in imaging of obstructed salivary glands can improve diagnostic outcomes. Oral Maxillofac Surg. 2013;17(1):11-9 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22562281
- Burke CJ, Thomas RH, Howlett D. Imaging the major salivary glands. Br J Oral Maxillofac Surg. 2011;49(4):261-9 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/20381221
- Onkar PM, Ratnaparkhi C, Mitra K. High-frequency ultrasound in parotid gland disease. Ultrasound Q. 2013;29(4):313-21 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/24263755
- Gritzmann. Sonography of the salivary glands. European Radiology. 2003;13(5):964-75 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/12695816
- Shimizu M, Okamura K, Kise Y, Takeshita Y, Furuhashi H, Weerawanich W, et al. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjogren's syndrome (SS), with an emphasis on sonography. Arthritis Res Ther. 2015;17:223 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/26298875
- Terraz S, Poletti PA, Dulguerov P, Dfouni N, Becker CD, Marchal F, et al. How reliable is sonography in the assessment of sialolithiasis? AJR Am J Roentgenol. 2013;201(1):W104-9 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/23789681
- Bag AK, Cure JK, Chapman PR, Singhal A, Haneef Mohamed AW. Imaging of Inflammatory Disorders of Salivary Glands. Neuroimaging Clin N Am. 2018;28(2):255-72 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622118
- Rzepakowska A, Osuch-Wojcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E, Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol. 2017;274(8):3231-40 (Level II evidence). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500678/
- Liu Y, Li J, Tan YR, Xiong P, Zhong LP. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):238-45.e2 (Level I evidence). https://www.ncbi.nlm.nih.gov/pubmed/25577417
- Wu S, Liu G, Chen R, Guan Y. Role of ultrasound in the assessment of benignity and malignancy of parotid masses. Dentomaxillofac Radiol. 2012;41(2):131-5 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22116132
- Lobo R, Hawk J, Srinivasan A. A Review of Salivary Gland Malignancies: Common Histologic Types, Anatomic Considerations, and Imaging Strategies. Neuroimaging Clin N Am. 2018;28(2):171-82 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622112
- Brennan PA, Herd MK, Howlett DC, Gibson D, Oeppen RS. Is ultrasound alone sufficient for imaging superficial lobe benign parotid tumours before surgery? Br J Oral Maxillofac Surg. 2012;50(4):333-7 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/21371794
- Lee YYP, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. European journal of radiology. 2008;66(3):419-36 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/18337041
- Ugga L, Ravanelli M, Pallottino AA, Farina D, Maroldi R. Diagnostic work-up in obstructive and inflammatory salivary gland disorders. Acta Otorhinolaryngol Ital. 2017;37(2):83-93 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/28516970
- Abdel Razek AAK, Mukherji SK. State-of-the-Art Imaging of Salivary Gland Tumors. Neuroimaging Clin N Am. 2018;28(2):303-17 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622121
- Thoeny HC. Imaging of salivary gland tumours. Cancer Imaging. 2007;7:52-62 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/17485257
- Terra GT, Oliveira JX, Hernandez A, Lourenco SV, Arita ES, Cortes AR. Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma. Dentomaxillofac Radiol. 2017;46(1):20160257 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/27845594
- Murdoch-Kinch CA. Salivary gland imaging. J Calif Dent Assoc. 2011;39(9):649-54 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22034799
- Hanna E, Vural E, Prokopakis E, et al. The Sensitivity and Specificity of High-Resolution Imaging in Evaluating Perineural Spread of Adenoid Cystic Carcinoma to the Skull Base. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):238-245.e2 (Level I evidence). https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/484751
- Weon YC, Park SW, Kim HJ, Jeong HS, Ko YH, Park IS, et al. Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients. Neuroradiology. 2012;54(6):631-40 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22307272
- Bryan RN, Miller RH, Ferreyro RI, Sessions RB. Computed tomography of the major salivary glands. AJR, American journal of roentgenology. 1982;139(3):547-54 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/6981322
- Dong Y, Lei GW, Wang SW, Zheng SW, Ge Y, Wei FC. Diagnostic value of CT perfusion imaging for parotid neoplasms. Dentomaxillofac Radiol. 2014;43(1):20130237 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/24186883
- Kikuchi M, Koyasu S, Shinohara S, Imai Y, Hino M, Naito Y. Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study. PLoS One. 2016;11(2):e0148973 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/26849569
- Tryggvason G, Gailey MP, Hulstein SL, Karnell LH, Hoffman HT, Funk GF, et al. Accuracy of fine-needle aspiration and imaging in the preoperative workup of salivary gland mass lesions treated surgically. Laryngoscope. 2013;123(1):158-63 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22991236
- Sack, Sack M, Weber R, Weinstein G, Chalian A, Nisenbaum H, et al. Image-Guided Fine-Needle Aspiration of the Head and Neck. Archives of Otolaryngology - Head & Neck Surgery. 1998;124(10):1155-61 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/9776195
- Carlson ER. Diagnosis and management of salivary lesions of the neck. Atlas Oral Maxillofac Surg Clin North Am. 2015;23(1):49-61 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/25707565
- Gavin-Clavero MA, Uson-Bouthelier T, Jariod-Ferrer UM, Fernandez-Larranaga A, Pantilie B, Lobera-Molina F, et al. Accuracy of FNAC and CT in the differentiation of benign and malignant parotid tumours in a case series. Acta Otorrinolaringol Esp. 2018;69(1):25-9 (Level IV evidence). https://www.ncbi.nlm.nih.gov/pubmed/28844507
- Bhatia KSS, Dai YL. Routine and Advanced Ultrasound of Major Salivary Glands. Neuroimaging Clin N Am. 2018;28(2):273-93 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622119
- Feinstein AJ, Alonso J, Yang SE, St John M. Diagnostic Accuracy of Fine-Needle Aspiration for Parotid and Submandibular Gland Lesions. Otolaryngol Head Neck Surg. 2016;155(3):431-6 (Level IV evidence). https://www.ncbi.nlm.nih.gov/pubmed/27095051
- Yerli H, Aydin E, Haberal N, Harman A, Kaskati T, Alibek S. Diagnosing common parotid tumours with magnetic resonance imaging including diffusion-weighted imaging vs fine-needle aspiration cytology: a comparative study. Dentomaxillofac Radiol. 2010;39(6):349-55 (Level II evidence). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520240/
- Hasson O. Modern sialography for screening of salivary gland obstruction. J Oral Maxillofac Surg. 2010;68(2):276-80 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/20116695
- Kassem K, Safia A , Elhadi U. et al. Fine-needle aspiration or core needle biopsy? A meta-analysis of diagnostic accuracy and procedural outcomes in salivary gland tumors Europ J of Radiology 2026; 194:112532
Pathway User Guide
Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.
White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).
Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.
Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.
The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.
| SYMBOL | RRL | EFFECTIVE DOSE RANGE |
|---|---|---|
| None | 0 | |
| Minimal | < 1 millisieverts | |
| Low | 1-5 mSv | |
| Medium | 5-10 mSv | |
| High | >10 mSv |
Disclaimer
Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.
Spotted an error or outdated info? Click to tell us.
Clinical History and examination
Clinical history and examination are important to determine the most appropriate investigation(s).
There are many causes of salivary gland swelling. Clinical history and examination are important to determine the most appropriate investigation(s).
It is important to recognise “red flag” features in the history and clinical examination
To summarise the benefits of each imaging modality simply for this pathology:
|
Modality |
Benefits |
Disadvantages |
|
Ultrasound |
Economical No Radiation Can evaluate tumour borders/content Identifies calcified sialoliths |
Poorly visualises deep structures |
|
MRI |
Very good image resolution and tumour differentiation Good at assessing ductal anatomy |
Expensive Less accessible Susceptible to motion artefacts |
|
CT |
Accessible Identifies calcified sialoliths |
Radiation Poorly differentiates tumours Can be falsely reassuring |
|
Conventional sialography |
Widely available Excellent resolution of small ducts Potential for therapeutic intervention Identifies sialoliths |
Radiation Invasive May be technically difficult Contraindicated in acute infection
|
Red flag features
It is important to recognise “red flag” features in the history and clinical examination
- Patient age >60
- Rapid growth
- Cutaneous features such as tethering/ulceration
- Facial nerve palsy
- Suspected deep lobe of parotid, or minor gland involvement
- Cervical lymphadenopathy
- Past medical history of facial/skin cancer
Ultrasound
US is usually the first line imaging modality in undifferentiated salivary gland swelling
- Initial imaging modality of choice in undifferentiated salivary gland swelling.
- Ultrasound can be used to identify:
- Ductal dilation
- Calculi (particularly when ≥ 3mm)
- Abscess formation
- Alteration of the normal glandular morphology and differentiate salivary gland lumps due to systemic diseases (e.g. Sjögren’s syndrome vs. IgG4 related dacroadenitis and sialadenitis)
- Mass lesions
- With correlation with appropriate clinical history, diagnosis of the above can often be made with ultrasound alone.
- In patients with suspected sialolithiasis and with normal sonographic findings, further assessment with conventional or MR sialography is recommended.
- For mass lesions in the superficial parotid, submandibular and sublingual glands, ultrasound can be used for initial assessment to determine the margins and internal characteristics, and help differentiate malignant from benign neoplasms (sensitivity 52-73%, specificity 89-94%). That is, US may not confidently differentiate benign and malignant masses, and biopsy will be required. It is recommended that further assessment of neoplasms be performed with cross-sectional imaging (MRI) and/or imaging guided fine needle aspiration cytology.
- Ultrasound is of limited utility for imaging the deep lobe of the parotid and for the minor salivary glands.
- If deep tissue extension is suspected or malignancy is confirmed on cytology, either MRI or CT is necessary to evaluate tumour extent, local invasion and perineural spread.
Magnetic Resonance Imaging (MRI)
MRI is the recommended imaging modality to assess solid masses/neoplasms of the salivary glands
- Imaging modality of choice when there is a strong suspicion of salivary gland malignancy.
- MRI can differentiate between inflammatory and neoplastic lesions.
- MRI has better contrast resolution than CT which allows detailed delineation of tumour margins and accurate local staging. Perineural spread, bone invasion and meningeal infiltration can be assessed.
- For all tumours in the sublingual gland, MRI should be performed as the risk of malignancy is high. As a general rule, the proportion of malignant tumours increases as the salivary gland size decreases (parotid gland 20-30% malignant, submandibular 40-60%, minor salivary glands 50-80%, sublingual glands 70-90%)
- Sensitivity and specificity for MRI in differentiating malignant vs. benign salivary gland neoplasms are 83-86% and 85-92% respectively.
- When it comes to perineural spread of tumours, MRI has shown to have a sensitivity of 100% and specificity of 85%.
Computed Tomography (CT)
CT demonstrates abscess formation, calculi, major salivary duct dilatation, acute inflammation, and neoplasms
- Demonstrates abscess formation, calculi, major salivary duct dilatation and acute inflammation well.
- Nearly always considered second line to MRI.
- Potentially falsely reassuring with predominent false negatives, when compared to MRI.
- In current practice, minor role for identifying major and minor salivary gland tumours and detecting direct extension to adjacent structures (particularly when bony erosion is a concern), neural and lymphatic invasion.
- Can be used to help to differentiate malignant from benign neoplasms (sensitivity 74-90%, specificity 79-90%), however, the combination of sensitivity and specificity in MRI is higher than for CT.
- Rapid and cheap compared to MRI but involves exposure to ionising radiation to the head and neck. Useful to assess neoplasms when MRI is contraindicated or where access to MRI is limited.
Imaging-guided Fine Needle Aspiration Cytology (FNAC)
Image -guided sampling allows accurate differentiation between benign and malignant tumours of salivary glands
- Widely used for diagnosis of salivary gland tumours and can predict if the lesion is benign or malignant with an accuracy of 81-98%.
- Although the combined sensitivity (80-82%) and specificity (95-97%) of FNAC in differentiating malignant from benign tumours is high, there is a relatively high non-diagnostic rate of about 10% due to sampling errors. It is currently recommended that neoplasms be characterised with cross-sectional imaging in conjunction with FNAC for pre-surgical decision making.
Core needle biopsy (CNB)
Recent evidence from a meta-analysis reported that CNB provides much higher sensitivity than FNAC, similar high specificity, fewer non-diagnostic procedures (with less need for repeats) but a slightly increased (but rare) risk of haematoma .
Conventional Sialography
Conventional (radiographic) sialography provides detailed imaging of the salivary ductal system
- An invasive technique in which iodinated contrast is directly injected into the main ducts of the parotid or submandibular glands with radiographs obtained to allow detailed assessment of ductal strictures or presence of calculi.
- Can be combined with therapeutic salivary interventional procedures which focus on gland preservation (e.g. stone retrieval, balloon ductoplasty of strictures) in some centres.
- There are risks of complications such as damage to the orifice, overfilling and rupture of the ductal system, exacerbation of infection, and adverse reactions to contrast material.
- Conventional sialography is generally superior to MR sialography in demonstrating very small calculi and detailing the smallest ductal branches
- MR sialography is superior to conventional sialography in demonstrating parenchymal changes
- Conventional sialography is contraindicated when there is acute salivary gland infection
Computed Tomography (CT)
CT can identify small calculi, especially in the submandibular gland where the vast majority are radio-opaque. CT can also assess gland atrophy, variant anatomy and help surgical planning
Magnetic Resonance Sialography
MR sialography is a non-invasive alternative to conventional sialography
- Non-invasive method to characterise the ductal structure and identify calculi and stenosis of the parotid and submandibular glands.
- Several studies have demonstrated that MR sialography is generally as accurate as conventional sialography in detecting obstructions, stenosis and stricture of the main ducts.
- MR sialography is superior to conventional sialography in demonstrating parenchymal changes
- For the small percentage of radiolucent calculi, MR sialography has a role
